Explore the top 5 companies leading the Alzheimer’s drugs market in 2025, highlighting key treatments, innovations, and market impact.

Dec 8, 2025 · Acumen Pharmaceuticals is focused on discovering and developing best in class therapeutics and diagnostics for Alzheimer’s disease. Codiak Biosciences is developing multiple …

View the list and locations of 59 biotechnology companies engaged in Alzheimer's work.

Nov 18, 2024 · Top 10 Alzheimer's Disease Therapeutics Companies: Biogen, Merck, GSK, Novartis, JnJ, Bristol-Myers Squibb, Sanofi, Pfizer, Teva, AbbVie...

6 days ago · NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused …

Feb 12, 2025 · With a dynamic and evolving drug pipeline, pharmaceutical companies are increasingly focused on developing therapies that slow the disease’s progression and improve patient quality of life.

Aug 8, 2023 · Hedder: Which pharmaceutical companies or biotech firms are leading the way in Alzheimer's research and development, and how have they performed in recent years?

Oct 5, 2025 · Large pharma seeking proven efficacy: Biogen, Eli Lilly, and Roche have advanced candidates with substantial clinical data.

Feb 11, 2025 · The market is moderately concentrated by three companies capturing the share of 38.10% namely Eisai Co. Ltd., Novartis Pharmaceuticals Corp (Sandoz) & Abbvie. These firms put a …

Apr 16, 2024 · Discover the top 10 Alzheimer's therapeutics companies at the forefront of developing innovative treatments and advancing our understanding of this debilitating condition